Clough Capital Partners L P Elanco Animal Health Inc Transaction History

Clough Capital Partners L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$16.68 - $32.25 $1.69 Million - $3.26 Million	-101,100 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$25.29 - $29.45 $2.59 Million - $3.02 Million	-102,600 Reduced 50.37%	101,100 $2.98 Million
Q3 2019 Nov 14, 2019	SELL	$25.62 - $34.96 $2.97 Million - $4.06 Million	-116,100 Reduced 36.3%	203,700 $5.42 Million
Q2 2019 Aug 14, 2019	BUY	$31.11 - $34.79 $715,530 - $800,170	23,000 Added 7.75%	319,800 $10.8 Million
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $8.61 Million - $9.74 Million	296,800 New	296,800 $9.52 Million

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.